Bluemonte大型價值主動型ETF BVAL 深 滬
交易中 03-26 10:50:10 美东时间
28.1634
0.000
0.00%
華盛通- 最 高0.00
- 今 開28.1634
- 成交量 2股
- 最 低 0.00
- 昨 收 28.1634
- 總市值 2.12亿
- 52周最高 29.59
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 15.9413
- 委 比 52.94%
- 總股本 751.30万
- 歷史最高 29.59
- 量 比 0.05
- 振 幅 0.00%
- 歷史最低 11.2063
- 每 手 1
- 風險率 1.17%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Atara Plans FDA Type A Meeting on EBVALLO
The latest update is out from Atara Biotherapeutics ( ($ATRA) ). On March 12, 2...
03-12 20:37
Atara, Pierre Fabre seek FDA meeting on EBVALLO
Atara Biotherapeutics ( ($ATRA) ) just unveiled an announcement. On March 3, 20...
03-03 21:57
Atara Biotherapeutics Resubmits Tabelecleucel BLA to FDA, Awaits Regulatory Review Following Manufacturing Collaboration with Pierre Fabre Pharmaceuticals
Atara Biotherapeutics Inc. has resubmitted the Biologics License Application (BLA) for tabelecleucel to the U.S. Food and Drug Administration on July 11, 2025, following a rapid response to observatio...
2025-07-15 20:02
BUZZ-Atara Biotherapeutics rises after direct stock offering, business update
** Shares of Atara Biotherapeutics ATRA.O up 7% premarket to $7.07 after co announces equity raise and business update ** Thousand Oaks, California-based firm announces pricing ~2.4 mln shares, includ...
2025-05-15 21:25
Atara Biotherapeutics Inc. Resumes Clinical Trials for EBVALLO™ After FDA Lifts Hold
Atara Biotherapeutics Inc. has announced a significant regulatory update regarding its EBVALLO™ (tabelecleucel) program. The U.S. Food and Drug Administration (FDA) has lifted the clinical hold on Ata...
2025-05-06 05:09
BRIEF-Atara Biotherapeutics Provides Regulatory and Business Update on EBVALLOTM (tabelecleucel)
Jan 16 (Reuters) - Atara Biotherapeutics Inc ATRA.O: ATARA BIOTHERAPEUTICS PROVIDES REGULATORY AND BUSINESS UPDATE ON EBVALLOTM (TABELECLEUCEL) ATARA BIOTHERAPEUTICS INC: RECEIVED FDA COMPLETE RESPONS...
2025-01-16 21:36
